# Clinical Trial of NAC in Asthma

> **NCT02605824** · PHASE4 · TERMINATED · sponsor: **University of California, San Francisco** · enrollment: 1 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** n-acetylcystine
- **DRUG:** 0.9% saline

## Key facts

- **NCT ID:** NCT02605824
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-03
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** The study was closed after we determined that this albuterol/NAC regimen may be associated with excessive bronchoconstriction.
- **Last updated:** 2019-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02605824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02605824, "Clinical Trial of NAC in Asthma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02605824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*